Physician profile
Brian Liu
NPI 1184115024
$6,120.80
in general payments reported to CMS, 2019-2025
11 companies · $262 in 2025
The $262 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.00 · 2022: $242 · 2023: $195 · 2024: $5,406 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $5,000 · Food and Beverage: $637 · Education: $226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $5,000.00 |
| Food and Beverage | $636.96 |
| Education | $225.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,370.71 | 2022-2025 | Symplicity G3 |
| Abbott Laboratories | $284.56 | 2023-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, Gallant |
| Boston Scientific Corporation | $99.88 | 2025 | Ingevity+ |
| Astellas Pharma US INC | $99.00 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $97.19 | 2023 | |
| Kestra Medical Technology Services, INC. | $54.43 | 2024 | Assure Wcd |
| Amgen INC. | $29.20 | 2024 | |
| Pfizer INC. | $26.02 | 2023 | |
| Janssen Pharmaceuticals, INC | $24.37 | 2022 | |
| Chiesi USA, INC. | $19.44 | 2023 | Kengreal, Cleviprex |
| Terumo Medical Corporation | $16.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.